SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-009983
Filing Date
2018-07-13
Accepted
2018-07-13 16:27:05
Documents
85
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1264033
2 ex31-1.htm EX-31.1 18175
3 ex31-2.htm EX-31.2 18113
4 ex32-1.htm EX-32.1 7212
5 ex32-2.htm EX-32.2 7102
  Complete submission text file 0001493152-18-009983.txt   5223496

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20180331.xml EX-101.INS 809842
7 XBRL SCHEMA FILE aker-20180331.xsd EX-101.SCH 66403
8 XBRL CALCULATION FILE aker-20180331_cal.xml EX-101.CAL 66014
9 XBRL DEFINITION FILE aker-20180331_def.xml EX-101.DEF 229495
10 XBRL LABEL FILE aker-20180331_lab.xml EX-101.LAB 426321
11 XBRL PRESENTATION FILE aker-20180331_pre.xml EX-101.PRE 342176
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 18952760
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1